首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1375086

北美药物输送市场预测至 2028 年 - COVID-19 影响和区域分析 - 按给药途径、配销通路和最终用户

North America Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Route of Administration, Distribution Channel, and End User

出版日期: 2023年08月21日 | 出版商:

The Insight Partners | 英文 233 Pages | 订单完成后即时交付

价格

简介目录图表

北美给药市场预计将从2023年的9,746.3953亿美元成长到2028年的14,2941,779万美元。预计2023年至2028年的复合年增长率为8.0%。

慢性病发生率上升推动北美药物传输市场

根据美国疾病管制与预防中心 (CDC) 的数据，截至 2019 年，美国约有十分之六的人患有至少一种慢性病，而约十分之四的人患有两种或两种以上慢性病。随着时间的推移病情恶化，对患者家庭和社会造成巨大负担。根据美国癌症协会 (ACS) 的预测，到 2023 年，美国可能会新增约 1,958,310 例癌症病例，并有 609,820 人死亡。糖尿病是一种危及生命的慢性疾病，没有专门的治疗方法。所有类型的糖尿病都会导致身体不同部位出现各种併发症，并增加过早死亡的风险。心臟病、中风、肾衰竭、截肢、视力丧失和神经损伤是与这种疾病相关的主要併发症。全球范围内糖尿病病例显着增加。

过去几十年来，慢性病盛行率的增加促进了药物输送系统的更深入的研究和开发（R&D）。用于治疗慢性疾病的药物的治疗功效可以透过最佳的药物传递系统来提高，例如奈米颗粒（例如陶瓷、聚合物和金属）、胶束、脂质体和树枝状聚合物。透过药物递送系统施用药物还可以帮助减少药物的全身副作用。已经引入了各种药物递送载体，用于针对多种慢性疾病（如糖尿病、癌症、动脉粥样硬化、心肌缺血、哮喘、肺结核、帕金森氏症和阿兹海默症）进行靶向和受控的治疗。适当的药物传递系统可确保药物长期具有高生物利用度，进而增强任何药物的治疗功效。标靶药物递送系统（TDDS）以受控方式在受试者体内预先选定的部位释放药物。基于奈米技术的传输系统正在对癌症治疗产生重大影响，而聚合物在这些奈米颗粒载体的开发中发挥关键作用。除了给药途径的多功能性之外，奈米治疗药物递送系统（NDDS）的一些值得注意的技术优势是延长半衰期、改善生物分布、增加药物循环时间、控制和持续药物释放以及提高细胞间药物浓度。

鑑于这些疾病的慢性性质，慢性病患者依赖持续的药物治疗，这与持续的副作用风险有关。开发合适的标靶药物递送系统可以促进标靶药物在致病病灶中的积累，减少全身性副作用，改善患者预后。因此，慢性病和生活方式疾病发生率的增加促进了北美给药系统市场的成长。

北美药物输送市场概况

北美是最大的给药市场，其中美国占最大的市场份额，其次是加拿大。北美市场成长的特点是生物製药和生物技术公司对罕见疾病药物的需求增加、主要市场参与者的存在以及各个学术和研究机构进行的广泛研发。此外，製药和生物技术公司的广泛研究预计将在预测期内支持北美药物传输市场的成长。

北美给药市场收入及 2028 年预测（百万美元）

北美给药市场细分

北美给药市场根据给药途径、配销通路、最终用户和国家进行细分。

根据给药途径，北美给药市场分为注射给药、口服给药、经黏膜给药、局部给药、植入式给药及眼部给药。 2023年，注射给药市场占据北美给药市场的最大份额。

根据配销通路，北美给药市场分为医院药房、零售药房和网路药房。 2023年，医院药局领域占据北美给药市场的最大份额。

根据最终用户，北美给药市场分为医院和诊所、家庭护理机构和其他最终用户。 2023 年，医院和诊所细分市场在北美给药市场中占据最大份额。

根据国家/地区，北美给药市场分为美国、加拿大和墨西哥。 2023年，美国主导北美给药市占率。

Bausch Health Companies Inc、Baxter International Inc.、Becton Dickinson and Co、勃林格殷格翰国际有限公司、波士顿科学公司、Gerresheimer AG、葛兰素史克Plc、强生公司、Kindeva Drug Delivery LP、诺华AG、诺和诺德AS、辉瑞Inc 和Sever Pharma Solutions 是北美药物输送市场的领导公司。

市场驱动因素
- 慢性病发生率上升
- 对非侵入性给药系统的需求不断增长
- 药厂研发支出增加
主要市场限制
- 与药物和输送系统开发相关的高成本
- 药物输送系统中的产品召回
主要市场机会
- 专注于提高病患依从性
未来的趋势
- 策略发展和产品发布
影响分析

第 6 章：药物输送市场 - 北美分析

北美给药市场收入预测与分析

第 7 章：北美药物输送市场 - 2028 年收入和预测 - 按给药途径

概述
北美药物输送市场收入份额，依给药途径划分（2022 年和 2028 年）
注射给药
口服给药
局部给药
经由黏膜给药
植入式药物输送
眼部药物输送

第 8 章：北美药物输送市场 - 2028 年收入和预测 - 按配销通路

概述
北美给药系统市场收入份额，按配销通路划分（2022 年和 2028 年）
医院药房
零售药局
网路药局

第 9 章：北美药物输送市场 - 2028 年收入和预测 - 按最终用户

概述
北美给药系统市场收入份额，按最终用户划分（2022 年和 2028 年）
医院和诊所
家庭护理设置
其他最终用户

第 10 章：北美药物输送市场 - 2028 年收入与预测 - 国家分析

- 我们
- 加拿大
- 墨西哥

第 11 章：北美药物输送市场 - 产业格局

概述
北美给药市场的成长策略
有机成长策略
- 概述
无机成长策略
- 概述

第 12 章：公司简介

Becton Dickinson and Co
Novo Nordisk AS
Boston Scientific Corp
Baxter International Inc
Gerresheimer AG
Kindeva Drug Delivery LP
GlaxoSmithKline Plc

博士健康公司

主要事实
业务描述
产品与服务
财务概览
SWOT分析
主要进展

勃林格殷格翰国际股份有限公司

主要事实
业务描述
产品与服务
财务概览
SWOT分析
主要进展

诺华公司

主要事实
业务描述
产品与服务
财务概览
SWOT分析
主要进展

塞弗製药解决方案

主要事实
业务描述
产品与服务
财务概览
SWOT分析
主要进展

强生公司

主要事实
业务描述
产品与服务
财务概览
SWOT分析
主要进展

辉瑞公司

主要事实
业务描述
产品与服务
财务概览
SWOT分析
主要进展

第 13 章：附录

关于 Insight Partners
专业术语

简介目录图表

Product Code: BMIRE00028761

The North America drug delivery market is expected to grow from US$ 9,74,639.53 million in 2023 to US$ 14,29,417.79 million by 2028. It is estimated to register a CAGR of 8.0% from 2023 to 2028.

Rising Incidence of Chronic Diseases Fuel North America Drug Delivery Market

According to the Centers for Disease Control and Prevention (CDC), ~6 in 10 people in the US suffered from at least one chronic disease, while ~4 in 10 people had two or more chronic diseases as of 2019. Patients suffering from chronic medical conditions deteriorate with time, resulting in an enormous burden on patients' families and society. According to the projections of the American Cancer Society (ACS), the US is likely to record ~1,958,310 new cancer cases and 609,820 deaths in 2023. Diabetes is a life-threatening chronic disease with no specialized cure. All types of diabetes can lead to various complications in different body parts and increase the risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with this disease. Cases of diabetes have been increasing significantly across the globe.

The increased prevalence of chronic diseases has promoted more intensive research and development (R&D) in drug delivery systems in the past few decades. The therapeutic efficacy of drugs used to treat chronic disease can be improved with optimal drug delivery systems, such as nanoparticles (e.g., ceramic, polymeric, and metallic), micelles, liposomes, and dendrimers. Administration of a drug with a drug delivery system can also help reduce systemic side effects of drugs. Various drug delivery vehicles have been introduced for a targeted and controlled delivery of therapeutics against a wide range of chronic diseases, such as diabetes, cancer, atherosclerosis, myocardial ischemia, asthma, pulmonary tuberculosis, Parkinson's, and Alzheimer's. An appropriate drug delivery system enhances the therapeutic efficacy of any drug by ensuring high drug bioavailability for a long duration. Targeted drug delivery systems (TDDS) release drugs in a controlled manner at a preselected site in a subject's body. Nanotechnology-based delivery systems are making a significant impact on cancer treatment, and polymers play a key role in the development of these nanoparticulate carriers. In addition to the versatility of the administration route, a few of the noteworthy technological advantages of nanotherapeutic drug delivery systems (NDDS) are prolonged half-life, improved biodistribution, increased drug circulation time, controlled and sustained drug release, and elevated intercellular drug concentration.

Given the chronic nature of these conditions, patients with chronic diseases rely on continuous drug treatment, which is associated with an ongoing risk of side effects. Developing appropriate delivery systems for targeted drugs can promote the accumulation of targeted medicines in pathogenic lesions, reduce systemic side effects, and improve patient outcomes. Thus, the increasing incidences of chronic and lifestyle diseases bolster the growth of the North America drug delivery systems market.

North America Drug Delivery Market Overview

North America is the largest market for drug delivery, with the US holding the largest market share, followed by Canada. The market growth in North America is characterized by increased demand for rare disease medications from biopharmaceutical and biotechnology companies, the presence of key market players, and extensive R&D conducted by various academic and research institutes. In addition, extensive research in pharmaceutical and biotechnology companies is expected to support the growth of the drug delivery market in North America during the forecast period.

North America Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

North America Drug Delivery Market Segmentation

The North America drug delivery market is segmented on the basis of route of administration, distribution channel, end user, and country.

Based on route of administration, the North America drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held the largest share of the North America drug delivery market in 2023.

Based on distribution channel, the North America drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the North America drug delivery market in 2023.

Based on end user, the North America drug delivery market is segmented into hospitals and clinics, home care settings, and other end users. The hospitals and clinics segment held the largest share of the North America drug delivery market in 2023.

Based on country, the North America drug delivery market is segmented into the US, Canada, and Mexico. The US dominated the share of the North America drug delivery market in 2023.

Bausch Health Companies Inc, Baxter International Inc., Becton Dickinson and Co, Boehringer Ingelheim International GmbH, Boston Scientific Corp, Gerresheimer AG, GlaxoSmithKline Plc, Johnson & Johnson, Kindeva Drug Delivery LP, Novartis AG, Novo Nordisk AS, Pfizer Inc, and Sever Pharma Solutions are the leading companies operating in the North America drug delivery market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America drug delivery market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Drug Delivery Market - by Route of Administration
- 1.3.2 North America Drug Delivery Market - by Distribution Channel
- 1.3.3 North America Drug Delivery Market - by End User
- 1.3.4 North America Drug Delivery Market - by Country

2. North America Drug Delivery Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Drug Delivery Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Expert's Opinion

5. North America Drug Delivery Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Incidence of Chronic Diseases
- 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
- 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Key Market Restraints
- 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
- 5.2.2 Product Recalls in Drug Delivery Systems
5.3 Key Market Opportunities
- 5.3.1 Focus on Improving Patient Compliance
5.4 Future Trends
- 5.4.1 Strategic Developments and Product Launches
5.5 Impact analysis

6. Drug Delivery Market - North America Analysis

6.1 North America Drug Delivery Market Revenue Forecast and Analysis

7. North America Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration

7.1 Overview
7.2 North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
7.3 Injectable Drug Delivery
- 7.3.1 Overview
- 7.3.2 Injectable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.3.2.1 Conventional Injection Devices
    - 7.3.2.1.1 Overview
    - 7.3.2.1.2 Conventional Injection Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.3.2.2 Advanced Devices
    - 7.3.2.2.1 Overview
    - 7.3.2.2.2 Advanced Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Oral Drug Delivery
- 7.4.1 Overview
- 7.4.2 Oral Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.1 Solid Oral Drugs
    - 7.4.2.1.1 Overview
    - 7.4.2.1.2 Solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.2 Liquid Oral Drugs
    - 7.4.2.2.1 Overview
    - 7.4.2.2.2 Liquid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.4.2.3 Semi-solid Oral Drugs
    - 7.4.2.3.1 Overview
    - 7.4.2.3.2 Semi-solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Topical Drug Delivery
- 7.5.1 Overview
- 7.5.2 Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.1 Semi-solid Topical Drug Delivery
    - 7.5.2.1.1 Overview
    - 7.5.2.1.2 Semi-solid Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.2 Liquid Topical Drug Delivery Formulations
    - 7.5.2.2.1 Overview
    - 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.3 Solid Topical Drug Delivery Formulations
    - 7.5.2.3.1 Overview
    - 7.5.2.3.2 Solid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.5.2.4 Transdermal
    - 7.5.2.4.1 Overview
    - 7.5.2.4.2 Transdermal Patches: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Transmucosal Drug Delivery
- 7.6.1 Overview
- 7.6.2 Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.1 Pulmonary and Nasal Drug Delivery
    - 7.6.2.1.1 Overview
    - 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.2 Buccal and Sublingual Drug Delivery
    - 7.6.2.2.1 Overview
    - 7.6.2.2.2 Buccal and Sublingual Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.3 Rectal Transmucosal Drug Delivery
    - 7.6.2.3.1 Overview
    - 7.6.2.3.2 Rectal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.6.2.4 Vaginal Transmucosal Drug Delivery
    - 7.6.2.4.1 Overview
    - 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Implantable Drug Delivery
- 7.7.1 Overview
- 7.7.2 Implantable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Ocular Drug Delivery
- 7.8.1 Overview
- 7.8.2 Ocular Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.1 Eye Drops and Sprays
    - 7.8.2.1.1 Overview
    - 7.8.2.1.2 Eye Drops and Sprays: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.2 Gels and Ointments
    - 7.8.2.2.1 Overview
    - 7.8.2.2.2 Gels and Ointments: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.3 Ocular Inserts and Punctal Plugs
    - 7.8.2.3.1 Overview
    - 7.8.2.3.2 Ocular Inserts and Punctal Plugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
  - 7.8.2.4 Therapeutic Contact Lens
    - 7.8.2.4.1 Overview
    - 7.8.2.4.2 Therapeutic Contact Lens: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel

8.1 Overview
8.2 North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
8.3 Hospital Pharmacies
- 8.3.1 Overview
- 8.3.2 Hospital Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Retail Pharmacies
- 8.4.1 Overview
- 8.4.2 Retail Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Online Pharmacies
- 8.5.1 Overview
- 8.5.2 Online Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Drug Delivery Market - Revenue and Forecast to 2028 - By End User

9.1 Overview
9.2 North America Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals and Clinics
- 9.3.1 Overview
- 9.3.2 Hospitals and Clinics: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Home Care Settings
- 9.4.1 Overview
- 9.4.2 Home Care Settings: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Other End User
- 9.5.1 Overview
- 9.5.2 Other End User: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
  - 10.1.1.1 US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.1.3.1 US: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.2 US: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.3 US: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.4 US: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.3.5 US: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.1.4 US: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.1.5 US: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.2 Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.2.3.1 Canada: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.2 Canada: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.3 Canada: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.4 Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.3.5 Canada: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Canada: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Canada: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)
  - 10.1.1.3 Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: North America Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
    - 10.1.1.3.3.1 Mexico: North America Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.2 Mexico: North America Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.3 Mexico: North America Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.4 Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.3.5 Mexico: North America Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: North America Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: North America Drug Delivery Market, by End User 2020-2028 (US$ Million)

11. North America Drug Delivery Market - Industry Landscape

11.1 Overview
11.2 Growth Strategies in North America Drug Delivery Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Novo Nordisk AS
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Boston Scientific Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Baxter International Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Gerresheimer AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Kindeva Drug Delivery LP
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 GlaxoSmithKline Plc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
  - 12.7.5.1 Key Developments
12.8 Bausch Health Companies Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Boehringer Ingelheim International GmbH
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Novartis AG
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Sever Pharma Solutions
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Johnson & Johnson
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Pfizer Inc
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. US: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 2. US: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 3. US: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 4. US: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 5. US: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 6. US: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 7. US: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
Table 8. US: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 13. Canada: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Mexico: North America Drug Delivery Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: North America Drug Delivery Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: North America Drug Delivery Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 20. Mexico: North America Drug Delivery Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico: North America Drug Delivery Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico: North America Drug Delivery Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico: North America Drug Delivery Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico: North America Drug Delivery Market, by End User - Revenue and Forecast to 2028 (US$ Million)
Table 25. Recent Organic Growth Strategies in North America Drug Delivery Market
Table 26. Recent Inorganic Growth Strategies in the North America Drug Delivery Market
Table 27. Glossary of Terms, North America Drug delivery market

List Of Figures

Figure 1. North America Drug Delivery Market Segmentation
Figure 2. North America Drug Delivery Market by Country
Figure 3. North America Drug Delivery Market Overview
Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in North America Drug Delivery Market
Figure 5. The US Expected to Show Remarkable Growth During Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Experts' Opinion
Figure 8. North America Drug Delivery Market Impact Analysis of Drivers and Restraints
Figure 9. North America Drug Delivery Market - Revenue Forecast and Analysis - 2020-2028
Figure 10. North America Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
Figure 11. Injectable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 12. Conventional Injection Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 13. Advanced Devices: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 14. Oral Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 15. Solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 16. Liquid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 17. Semi-solid Oral Drugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 18. Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 19. Semi-solid Topical Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 20. Liquid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Solid Topical Drug Delivery Formulations: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Transdermal Patches: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Pulmonary Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Buccal and Sublingual Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rectal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Vaginal Transmucosal Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. Implantable Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Ocular Drug Delivery: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Eye Drops and Sprays: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Gels and Ointments: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Ocular Inserts and Punctal Plugs: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Therapeutic Contact Lens: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
Figure 35. Hospital Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Retail Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Online Pharmacies: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
Figure 39. Hospitals and Clinics: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Home Care Settings: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Other End User: North America Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. North America Drug Delivery Systems Market, by Key Country - Revenue (2022) (US$ Million)
Figure 43. North America Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
Figure 44. US: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Canada: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Mexico: North America Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Growth Strategies in North America Drug Delivery Market